UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION
UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934
OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934.
| Commission File Numbers: | 333-184122 | |
| 333-223089-01 | ||
| 333-202168-03 | ||
| 333-199019-01 |
Allergan Finance, LLC
(Exact name of registrant as specified in its charter)
5 Giralda Farms
Madison, NJ 07940
(862)261-7000
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
3.250% notes due 2022
4.625% notes due 2042
Guarantees of Allergan Funding SCS’s Floating Rate notes due 2020
Guarantees of Allergan Funding SCS’s 0.500% notes due 2021
Guarantees of Allergan Funding SCS’s 3.450% notes due 2022
Guarantees of Allergan Funding SCS’s 1.500% notes due 2023
Guarantees of Allergan Funding SCS’s 1.250% notes due 2024
Guarantees of Allergan Funding SCS’s 3.850% notes due 2024
Guarantees of Allergan Funding SCS’s 3.800% notes due 2025
Guarantees of Allergan Funding SCS’s 2.625% notes due 2028
Guarantees of Allergan Funding SCS’s 2.125% notes due 2029
Guarantees of Allergan Funding SCS’s 4.550% notes due 2035
Guarantees of Allergan Funding SCS’s 4.850% notes due 2044
Guarantees of Allergan Funding SCS’s 4.750% notes due 2045
(Title of each class of securities covered by this Form)
None
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
Rule 12g-4(a)(1) | ☒ | |||||
Rule12g-4(a)(2) | ☐ | |||||
Rule12h-3(b)(1)(i) | ☒ | |||||
Rule12h-3(b)(1)(ii) | ☐ | |||||
Rule15d-6 | ☐ | |||||
Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date:
3.250% notes due 2022: Less than 300 holders
4.625% notes due 2042: Less than 300 holders
Guarantees of Allergan Funding SCS’s Floating Rate notes due 2020: Zero (0) holders
Guarantees of Allergan Funding SCS’s 0.500% notes due 2021: Zero (0) holders
Guarantees of Allergan Funding SCS’s 3.450% notes due 2022: Zero (0) holders
Guarantees of Allergan Funding SCS’s 1.500% notes due 2023: Zero (0) holders
Guarantees of Allergan Funding SCS’s 1.250% notes due 2024: Zero (0) holders
Guarantees of Allergan Funding SCS’s 3.850% notes due 2024: Zero (0) holders
Guarantees of Allergan Funding SCS’s 3.800% notes due 2025: Zero (0) holders
Guarantees of Allergan Funding SCS’s 2.625% notes due 2028: Zero (0) holders
Guarantees of Allergan Funding SCS’s 2.125% notes due 2029: Zero (0) holders
Guarantees of Allergan Funding SCS’s 4.550% notes due 2035: Zero (0) holders
Guarantees of Allergan Funding SCS’s 4.850% notes due 2044: Zero (0) holders
Guarantees of Allergan Funding SCS’s 4.750% notes due 2045: Zero (0) holders
Pursuant to the requirements of the Securities Exchange Act of 1934, Allergan Finance, LLC has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
Date: May 21, 2020 | Allergan Finance, LLC | |||||
By: | /s/ Robert A. Michael | |||||
| Name: | Robert A. Michael | |||||
| Title: | President | |||||
